(MedPage Today) — CHICAGO — Almost two-thirds of teens with plaque psoriasis saw complete skin clearance after 6 months of treatment with icotrokinra, an investigational oral peptide drug that blocks interleukin-23 (IL-23), according to phase…
Source link : https://www.medpagetoday.com/meetingcoverage/acr/118165
Author :
Publish date : 2025-10-27 19:29:00
Copyright for syndicated content belongs to the linked Source.
